# SMAD5

## Overview
SMAD5 is a gene that encodes the SMAD family member 5 protein, which is a receptor-regulated SMAD (R-SMAD) involved in the bone morphogenetic protein (BMP) signaling pathway, part of the transforming growth factor-beta (TGF-β) superfamily. The SMAD5 protein plays a crucial role in signal transduction and transcriptional regulation, primarily through its two conserved domains: the MH1 domain, responsible for DNA binding, and the MH2 domain, which facilitates transactivation and oligomerization (Miyazono2018Structural; Shi1998Crystal). SMAD5 is integral to cellular processes such as bioenergetic homeostasis, where it acts as an intracellular pH messenger, influencing glycolysis and mitochondrial respiration (Fang2017Smad5). Additionally, SMAD5 is involved in various protein interactions that are essential for its function in cellular signaling pathways, including its role in embryonic development and angiogenesis (Orlowski2017SMAD5; Conidi2011Few). Alterations in SMAD5 expression have been linked to several cancers, highlighting its clinical significance (Wang2023SMAD).

## Structure
The SMAD5 protein is a member of the SMAD family, characterized by its involvement in signal transduction and transcriptional regulation. It contains two conserved domains: the MH1 domain, responsible for DNA binding, and the MH2 domain, which facilitates transactivation and oligomerization (Shi1998Crystal). The MH1 domain of SMAD5 adopts a compact globular fold with four alpha-helices, six short beta-strands, and five loops, featuring a novel DNA-binding motif known as the beta-hairpin (Hariharan2006Homology). This beta-hairpin motif is crucial for DNA interaction, allowing SMAD5 to bind to both classical CAGAC SBEs and GC-rich motifs, demonstrating its adaptability in recognizing various DNA sequences (MartinMalpartida2017Structural).

The MH2 domain is highly conserved among SMAD proteins, sharing significant sequence identity with other receptor-regulated SMADs (R-SMADs) like SMAD1 and SMAD8 (Miyazono2018Structural). SMAD5 undergoes phosphorylation, a common post-translational modification that influences its activity and interactions, particularly in the context of TGF-β signaling pathways (Chaikuad2016Structural). The nuclear localization signal of SMAD5 is mapped to the N-terminal alpha helix 2, and key residues involved in zinc atom coordination are conserved, contributing to its structural integrity and function (Hariharan2006Homology).

## Function
SMAD5 is a critical component of the bone morphogenetic protein (BMP) signaling pathway, which is part of the transforming growth factor-beta (TGF-β) superfamily. It functions as a receptor-regulated SMAD protein, activated by BMP signaling, and is involved in mediating intracellular signaling by translocating into the nucleus to influence gene expression (Nie2015miR23a; Jüllig2003Mitochondrial). SMAD5 plays a significant role in maintaining bioenergetic homeostasis in healthy human cells by acting as an intracellular pH messenger. It regulates glycolysis and mitochondrial respiration in a transcription-independent manner, maintaining cellular bioenergetic states (Fang2017Smad5; Orlowski2017SMAD5).

SMAD5 is sensitive to intracellular pH changes, shuttling between the cytoplasm and nucleus in response to environmental factors such as temperature and osmolarity. This shuttling is crucial for its role in bioenergetic regulation, as it interacts with hexokinase 1 to accelerate glycolysis (Fang2017Smad5). SMAD5's cytoplasmic presence is essential for maintaining normal cellular homeostasis, and its deficiency leads to mitochondrial dysfunction and impaired glycolytic rates (Fang2017Smad5). The protein's noncanonical role in responding to pH changes and regulating cellular bioenergetic states highlights its importance in cellular metabolism and homeostasis (Fang2017Smad5).

## Clinical Significance
SMAD5 is implicated in various cancers due to alterations in its expression levels. In chronic lymphocytic leukemia (CLL), increased expression of SMAD5 is associated with shorter patient survival, indicating its potential role in disease progression and prognosis (Wang2023SMAD). In gastric cancer, elevated levels of SMAD5 correlate with poorer clinical outcomes, suggesting its involvement in cancer aggressiveness and treatment response (Wang2023SMAD).

Despite its involvement in cancer, studies have not identified germline mutations in SMAD5 as a cause of juvenile polyposis syndrome (JPS). Research screening for mutations in SMAD5 among JPS patients found no pathogenic variants, suggesting that SMAD5 mutations are not a contributing factor to this condition (Bevan1999Screening).

In the context of pulmonary arterial hypertension (PAH), SMAD5 has been analyzed for potential mutations, but no significant variants have been identified, indicating that SMAD5 mutations are infrequent in PAH pathogenesis (Nasim2011Molecular). Overall, while SMAD5 is involved in several disease processes through altered expression, direct mutations in the gene have not been conclusively linked to specific genetic disorders.

## Interactions
SMAD5 is involved in various protein interactions that are crucial for its role in cellular signaling pathways. It forms stable complexes with BMPR-IB receptors, which are essential for the signaling of osteogenic protein-1 (OP-1) in rat osteoprogenitor-like cells. This interaction is specific to SMAD5, as SMAD2 and SMAD3 do not form such complexes with BMPR-IB (Tamaki1998Intracellular). SMAD5 also interacts with SMAD4 to enhance OP-1 responsiveness, indicating a cooperative role in signaling pathways (Tamaki1998Intracellular).

In the context of embryonic development, SMAD5 forms unconventional complexes with SMAD2, which antagonize Nodal signaling, preventing ectopic primitive streak formation (Conidi2011Few). SMAD5 is also involved in angiogenesis, where it interacts with Notch signaling to regulate the specification of tip and stalk cells in blood vessel formation (Conidi2011Few).

SMAD5 has a unique cytoplasmic function independent of receptor signaling, where it interacts with hexokinase 1 (HK1) to enhance glycolysis rates, demonstrating its role in cellular bioenergetic homeostasis (Orlowski2017SMAD5). These interactions highlight the diverse roles of SMAD5 in cellular processes and its importance in various signaling pathways.


## References


[1. (Bevan1999Screening) S Bevan, K Woodford-Richens, P Rozen, C Eng, J Young, M Dunlop, K Neale, R Phillips, D Markie, M Rodriguez-Bigas, B Leggett, E Sheridan, S Hodgson, T Iwama, D Eccles, W Bodmer, R Houlston, and I Tomlinson. Screening smad1,smad2, smad3, andsmad5 for germline mutations in juvenile polyposis syndrome. Gut, 45(3):406–408, September 1999. URL: http://dx.doi.org/10.1136/gut.45.3.406, doi:10.1136/gut.45.3.406. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gut.45.3.406)

[2. (Wang2023SMAD) Qi Wang, Fei Xiong, Guanhua Wu, Da Wang, Wenzheng Liu, Junsheng Chen, Yongqiang Qi, Bing Wang, and Yongjun Chen. Smad proteins in tgf-β signalling pathway in cancer: regulatory mechanisms and clinical applications. Diagnostics, 13(17):2769, August 2023. URL: http://dx.doi.org/10.3390/diagnostics13172769, doi:10.3390/diagnostics13172769. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/diagnostics13172769)

[3. (Nie2015miR23a) Mingyue Nie, Song Yu, Sha Peng, Ying Fang, Hongmei Wang, and Xiaokui Yang. Mir-23a and mir-27a promote human granulosa cell apoptosis by targeting smad51. Biology of Reproduction, October 2015. URL: http://dx.doi.org/10.1095/biolreprod.115.130690, doi:10.1095/biolreprod.115.130690. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1095/biolreprod.115.130690)

[4. (Nasim2011Molecular) Md. Talat Nasim, Takeshi Ogo, Mohammad Ahmed, Rebecca Randall, Hasnin M. Chowdhury, Katie M. Snape, Teisha Y. Bradshaw, Laura Southgate, Grace J. Lee, Ian Jackson, Graham M. Lord, J. Simon R. Gibbs, Martin R. Wilkins, Keiko Ohta-Ogo, Kazufumi Nakamura, Barbara Girerd, Florence Coulet, Florent Soubrier, Marc Humbert, Nicholas W. Morrell, Richard C. Trembath, and Rajiv D. Machado. Molecular genetic characterization of smad signaling molecules in pulmonary arterial hypertension. Human Mutation, 32(12):1385–1389, October 2011. URL: http://dx.doi.org/10.1002/humu.21605, doi:10.1002/humu.21605. This article has 226 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21605)

[5. (Miyazono2018Structural) Ken-ichi Miyazono, Yosuke Ohno, Hikaru Wada, Tomoko Ito, Yui Fukatsu, Akira Kurisaki, Makoto Asashima, and Masaru Tanokura. Structural basis for receptor-regulated smad recognition by man1. Nucleic Acids Research, 46(22):12139–12153, October 2018. URL: http://dx.doi.org/10.1093/nar/gky925, doi:10.1093/nar/gky925. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gky925)

[6. (Fang2017Smad5) Yujiang Fang, Zhongliang Liu, Zhenyu Chen, Xiangjie Xu, Mengtao Xiao, Yanyan Yu, Yuanyuan Zhang, Xiaobai Zhang, Yanhua Du, Cizhong Jiang, Yuzheng Zhao, Yiran Wang, Beibei Fan, Daniel Terheyden-Keighley, Yang Liu, Lei Shi, Yi Hui, Xin Zhang, Bowen Zhang, Hexi Feng, Lin Ma, Quanbin Zhang, Guohua Jin, Yi Yang, Bin Xiang, Ling Liu, and Xiaoqing Zhang. Smad5 acts as an intracellular ph messenger and maintains bioenergetic homeostasis. Cell Research, 27(9):1083–1099, July 2017. URL: http://dx.doi.org/10.1038/cr.2017.85, doi:10.1038/cr.2017.85. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2017.85)

[7. (Tamaki1998Intracellular) Kiyoshi Tamaki, Serhiy Souchelnytskyi, Susumu Itoh, Atsuhito Nakao, Kuber Sampath, Carl-Henrik Heldin, and Peter Ten Dijke. Intracellular signaling of osteogenic protein-1 through smad5 activation. Journal of Cellular Physiology, 177(2):355–363, November 1998. URL: http://dx.doi.org/10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8, doi:10.1002/(sici)1097-4652(199811)177:2<355::aid-jcp17>3.0.co;2-8. This article has 99 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(SICI)1097-4652(199811)177:2)

[8. (Chaikuad2016Structural) Apirat Chaikuad and Alex N. Bullock. Structural basis of intracellular tgf-β signaling: receptors and smads. Cold Spring Harbor Perspectives in Biology, 8(11):a022111, August 2016. URL: http://dx.doi.org/10.1101/cshperspect.a022111, doi:10.1101/cshperspect.a022111. This article has 93 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/cshperspect.a022111)

[9. (Conidi2011Few) Andrea Conidi, Silvia Cazzola, Karen Beets, Kathleen Coddens, Clara Collart, Frederique Cornelis, Luk Cox, Debruyn Joke, Mariya P. Dobreva, Ruben Dries, Camila Esguerra, Annick Francis, Abdelilah Ibrahimi, Roel Kroes, Flore Lesage, Elke Maas, Ivan Moya, Paulo N.G. Pereira, Elke Stappers, Agata Stryjewska, Veronique van den Berghe, Liesbeth Vermeire, Griet Verstappen, Eve Seuntjens, Lieve Umans, An Zwijsen, and Danny Huylebroeck. Few smad proteins and many smad-interacting proteins yield multiple functions and action modes in tgfβ/bmp signaling in vivo. Cytokine &amp; Growth Factor Reviews, 22(5–6):287–300, October 2011. URL: http://dx.doi.org/10.1016/j.cytogfr.2011.11.006, doi:10.1016/j.cytogfr.2011.11.006. This article has 123 citations.](https://doi.org/10.1016/j.cytogfr.2011.11.006)

[10. (MartinMalpartida2017Structural) Pau Martin-Malpartida, Marta Batet, Zuzanna Kaczmarska, Regina Freier, Tiago Gomes, Eric Aragón, Yilong Zou, Qiong Wang, Qiaoran Xi, Lidia Ruiz, Angela Vea, José A. Márquez, Joan Massagué, and Maria J. Macias. Structural basis for genome wide recognition of 5-bp gc motifs by smad transcription factors. Nature Communications, December 2017. URL: http://dx.doi.org/10.1038/s41467-017-02054-6, doi:10.1038/s41467-017-02054-6. This article has 78 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-02054-6)

[11. (Hariharan2006Homology) Ramkumar Hariharan and M. Radhakrishna Pillai. Homology modeling of the dna-binding domain of human smad5: a molecular model for inhibitor design. Journal of Molecular Graphics and Modelling, 24(4):271–277, January 2006. URL: http://dx.doi.org/10.1016/j.jmgm.2005.09.009, doi:10.1016/j.jmgm.2005.09.009. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jmgm.2005.09.009)

[12. (Orlowski2017SMAD5) John Orlowski. Smad5 signaling: more than meets the nuclei. Cell Research, 27(9):1075–1076, August 2017. URL: http://dx.doi.org/10.1038/cr.2017.101, doi:10.1038/cr.2017.101. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2017.101)

[13. (Shi1998Crystal) Yigong Shi, Yan-Fei Wang, Lata Jayaraman, Haijuan Yang, Joan Massagué, and Nikola P. Pavletich. Crystal structure of a smad mh1 domain bound to dna. Cell, 94(5):585–594, September 1998. URL: http://dx.doi.org/10.1016/S0092-8674(00)81600-1, doi:10.1016/s0092-8674(00)81600-1. This article has 1009 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/S0092-8674(00)81600-1)

[14. (Jüllig2003Mitochondrial) Mia Jüllig and N.Susan Stott. Mitochondrial localization of smad5 in a human chondrogenic cell line. Biochemical and Biophysical Research Communications, 307(1):108–113, July 2003. URL: http://dx.doi.org/10.1016/s0006-291x(03)01139-2, doi:10.1016/s0006-291x(03)01139-2. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0006-291x(03)01139-2)